Panacea Life Sciences Holdings, Inc. (PLSH)

Market Cap	2.44M
Revenue (ttm)	2.38M
Net Income (ttm)	-8.90M
Shares Out	17.65M
EPS (ttm)	-0.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Open	0.138
Previous Close	0.138
Day's Range	0.138 - 0.138
52-Week Range	0.096 - 0.625
Beta	3.86
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PLSH

Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies for aspect of life under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand name. The company was incorporated...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Ms. Leslie A. Buttorff
• Employees: 19
• Stock Exchange: OTCMKTS
• Ticker Symbol: PLSH

Financial Performance

In 2023, PLSH's revenue was $2.38 million, an increase of 46.59% compared to the previous year's $1.63 million. Losses were -$8.02 million, -27.78% less than in 2022.